{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:32:35Z","timestamp":1790814755984,"version":"4.1.0"},"reference-count":94,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Congenital fibrinogen deficiencies (CFDs), traditionally considered rare monogenic disorders, are now recognized as more prevalent and genetically complex than previously thought. Indeed, the symptoms manifested in CFD patients, such as bleeding and thrombosis, are likely to result from variation in several genes rather than solely driven by variants in one of the three fibrinogen genes, FGB, FGA, and FGG. This review highlights recent advances in understanding the genetic causes of CFD and their variability, facilitated by the growing use and availability of next-generation sequencing data. Using gnomAD v4.1.0. data, which includes more than 800,000 individuals, we provide updated global prevalence estimates for CFDs based on frequencies of predicted deleterious variants in FGB, FGA, and FGG. Recessively inherited fibrinogen deficiencies (homozygous genotypes) could be present in around 29 individuals per million, while dominantly inherited deficiencies (heterozygous genotypes) may be present in up to 15,000 per million. These increased estimates can be attributed to the inclusion of broader, more diverse genetic datasets in the new version of gnomAD, thus capturing a greater range of rare variants and homozygous cases.<\/jats:p>","DOI":"10.1055\/a-2511-3314","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T20:07:56Z","timestamp":1741810076000},"page":"286-296","source":"Crossref","is-referenced-by-count":4,"title":["Congenital Fibrinogen Deficiencies: Not So Rare"],"prefix":"10.1055","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9593-4361","authenticated-orcid":false,"given":"Alexander","family":"Couzens","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva and Institute of Genetics and Genomics in Geneva (iGE3), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-4195","authenticated-orcid":false,"given":"Marguerite","family":"Neerman-Arbez","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva and Institute of Genetics and Genomics in Geneva (iGE3), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1619601","article-title":"Platelet and von Willebrand factor interactions at the vessel wall","volume":"24","author":"Z M Ruggeri","year":"2004","journal-title":"Hamostaseologie"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1749-6632.2001.tb03521.x","article-title":"Platelet-fibrinogen interactions","volume":"936","author":"J S Bennett","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0043-1775857","article-title":"Fifty years of fibrinogen structure and function","volume":"50","author":"M Neerman-Arbez","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-319-49674-0_13","article-title":"Fibrin formation, structure and properties","volume":"82","author":"J W Weisel","year":"2017","journal-title":"Subcell Biochem"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"100081","DOI":"10.1016\/j.rpth.2023.100081","article-title":"Fibrinolysis: an illustrated review","volume":"7","author":"R A Risman","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"21","key":"ref6","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1093\/hmg\/ddi360","article-title":"Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia","volume":"14","author":"D Vu","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.jtha.2023.08.014","article-title":"Fibrinogen and fibrin: synthesis, structure, and function in health and disease","volume":"21","author":"A S Wolberg","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"J P Luyendyk","year":"2019","journal-title":"Blood"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: both friend and foe","volume":"105","author":"R Vilar","year":"2020","journal-title":"Haematologica"},{"issue":"8566","key":"ref10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(87)92557-8","article-title":"Genetic and cultural inheritance of plasma fibrinogen concentration","volume":"2","author":"A Hamsten","year":"1987","journal-title":"Lancet"},{"issue":"9250","key":"ref11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(00)03541-8","article-title":"The genetics of haemostasis: a twin study","volume":"357","author":"M de Lange","year":"2001","journal-title":"Lancet"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2010-07-295410","article-title":"A liver enhancer in the fibrinogen gene cluster","volume":"117","author":"A Fort","year":"2011","journal-title":"Blood"},{"issue":"03","key":"ref13","first-page":"427","article-title":"A novel regulatory element between the human FGA and FGG genes","volume":"108","author":"R J Fish","year":"2012","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/jth.14248","article-title":"Local chromatin interactions contribute to expression of the fibrinogen gene cluster","volume":"16","author":"C Espitia Jaimes","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref16","first-page":"419","article-title":"Fibrinogen gene regulation","volume":"108","author":"R J Fish","year":"2012","journal-title":"Thromb Haemost"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"109134","DOI":"10.1016\/j.thromres.2024.109134","article-title":"Regulation of fibrinogen synthesis","volume":"242","author":"D A Dobson","year":"2024","journal-title":"Thromb Res"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1073\/pnas.91.7.2625","article-title":"Fib420: a normal human variant of fibrinogen with two extended \u03b1 chains","volume":"91","author":"Y Fu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"07","key":"ref19","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1182\/blood.V90.7.2609.2609_2609_2614","article-title":"Fib420, the novel fibrinogen subclass: newborn levels are higher than adult","volume":"90","author":"G Grieninger","year":"1997","journal-title":"Blood"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1749-6632.2001.tb03493.x","article-title":"Contribution of the \u03b1 EC domain to the structure and function of fibrinogen-420","volume":"936","author":"G Grieninger","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"21","key":"ref21","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1182\/bloodadvances.2020001472","article-title":"A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen A\u03b1E in early hemostasis","volume":"4","author":"C Freire","year":"2020","journal-title":"Blood Adv"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1055\/a-2102-4521","article-title":"Levels of fibrinogen variants are altered in severe COVID-19","volume":"7","author":"J J de Vries","year":"2023","journal-title":"TH Open"},{"issue":"21","key":"ref23","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1021\/bi00524a036","article-title":"Carboxy-terminal amino acid sequence of a human fibrinogen \u03b3-chain variant (\u03b3\u2032)","volume":"20","author":"C Wolfenstein-Todel","year":"1981","journal-title":"Biochemistry"},{"issue":"18","key":"ref24","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/bi00313a033","article-title":"\u03b3 and \u03b3\u2032 chains of human fibrinogen are produced by alternative mRNA processing","volume":"23","author":"D W Chung","year":"1984","journal-title":"Biochemistry"},{"issue":"09","key":"ref25","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1073\/pnas.77.9.5069","article-title":"Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal \u03b3 chain variant (\u03b3\u2032)","volume":"77","author":"C Wolfenstein-Todel","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2009.138347","article-title":"\u03b3\u2032 fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease","volume":"56","author":"R S Lovely","year":"2010","journal-title":"Clin Chem"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0036-1572353","article-title":"The (patho)physiology of fibrinogen \u03b3\u2032","volume":"42","author":"F L Macrae","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0042-1756187","article-title":"One hundred years of congenital fibrinogen disorders","volume":"48","author":"A Casini","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1055\/s-0041-1742170","article-title":"Mutations accounting for congenital fibrinogen disorders: an update","volume":"48","author":"M Richard","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"22","key":"ref30","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.2020009472","article-title":"Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia","volume":"137","author":"A Casini","year":"2021","journal-title":"Blood"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1055\/s-0038-1673685","article-title":"Mutational epidemiology of congenital fibrinogen disorders","volume":"118","author":"A Casini","year":"2018","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref32","first-page":"149","article-title":"Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia","volume":"96","author":"M Neerman-Arbez","year":"2000","journal-title":"Blood"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood.V97.6.1879","article-title":"Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T","volume":"97","author":"C Attanasio","year":"2001","journal-title":"Blood"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI5471","article-title":"Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia","volume":"103","author":"M Neerman-Arbez","year":"1999","journal-title":"J Clin Invest"},{"issue":"09","key":"ref35","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jth.14216","article-title":"Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH","volume":"16","author":"A Casini","year":"2018","journal-title":"J Thromb Haemost"},{"key":"ref36","first-page":"89","volume-title":"A database for human fibrinogen variants","author":"M Hanss","year":"2001"},{"issue":"05","key":"ref37","first-page":"685","article-title":"Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications","volume":"96","author":"C R Sheen","year":"2006","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0036-1571339","article-title":"Clinical features and management of congenital fibrinogen deficiencies","volume":"42","author":"A Casini","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/bloodadvances.2023012186","article-title":"Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database","volume":"8","author":"S Mohsenian","year":"2024","journal-title":"Blood Adv"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.thromres.2015.11.008","article-title":"Fibrin clot structure in patients with congenital dysfibrinogenaemia","volume":"137","author":"A Casini","year":"2016","journal-title":"Thromb Res"},{"issue":"08","key":"ref41","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V80.8.1972.1972","article-title":"Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A \u03b1 461-610 (Lys 461 AAA-->stop TAA)","volume":"80","author":"J Koopman","year":"1992","journal-title":"Blood"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","article-title":"Natural history of patients with congenital dysfibrinogenemia","volume":"125","author":"A Casini","year":"2015","journal-title":"Blood"},{"issue":"06","key":"ref43","doi-asserted-by":"crossref","first-page":"103203","DOI":"10.1016\/j.transci.2021.103203","article-title":"Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders","volume":"60","author":"S Mohsenian","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/hae.12967","article-title":"Can the phenotype of inherited fibrinogen disorders be predicted?","volume":"22","author":"A Casini","year":"2016","journal-title":"Haemophilia"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1172\/JCI115841","article-title":"Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B \u03b2 68 Ala----Thr","volume":"90","author":"J Koopman","year":"1992","journal-title":"J Clin Invest"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0038-1647646","article-title":"Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA","volume":"60","author":"L Engesser","year":"1988","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref47","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V82.8.2462.2462","article-title":"Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure","volume":"82","author":"J P Collet","year":"1993","journal-title":"Blood"},{"issue":"05","key":"ref48","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/jth.13655","article-title":"Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation","volume":"15","author":"A Casini","year":"2017","journal-title":"J Thromb Haemost"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1788898","article-title":"Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders","author":"A Casini","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcmd.2015.06.002","article-title":"Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia","volume":"55","author":"J Zhou","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"F Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI112430","article-title":"von Willebrand factor interaction with the glycoprotein IIb\/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia","volume":"77","author":"L De Marco","year":"1986","journal-title":"J Clin Invest"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0036-1571340","article-title":"Laboratory and genetic investigation of mutations accounting for congenital fibrinogen disorders","volume":"42","author":"M Neerman-Arbez","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/hae.14773","article-title":"Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies","volume":"29","author":"S Mohsenian","year":"2023","journal-title":"Haemophilia"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1111\/hae.14621","article-title":"Hemizygous FGG p.Ala108Gly in a hypofibrinogenemic patient with a heterozygous 14.8\u2009Mb deletion encompassing the entire fibrinogen gene cluster","volume":"28","author":"A Couzens","year":"2022","journal-title":"Haemophilia"},{"issue":"6475","key":"ref56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"R M Bertina","year":"1994","journal-title":"Nature"},{"issue":"10","key":"ref57","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"S R Poort","year":"1996","journal-title":"Blood"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood.V88.4.1183.bloodjournal8841183","article-title":"Moderation of hemophilia A phenotype by the factor V R506Q mutation","volume":"88","author":"W C Nichols","year":"1996","journal-title":"Blood"},{"issue":"08","key":"ref59","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V90.8.3067","article-title":"An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN)","volume":"90","author":"C van 't Veer","year":"1997","journal-title":"Blood"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"J C Gill","year":"1987","journal-title":"Blood"},{"issue":"25","key":"ref61","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"S E Ward","year":"2020","journal-title":"Blood"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"D10","DOI":"10.1093\/nar\/gkaa892","article-title":"Database resources of the National Center for Biotechnology Information","volume":"49","author":"E W Sayers","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"7319","key":"ref63","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"G R Abecasis","year":"2010","journal-title":"Nature"},{"issue":"08","key":"ref64","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: lessons from gnomAD","volume":"43","author":"S Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"issue":"7920","key":"ref65","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-022-04965-x","article-title":"The sequences of 150,119 genomes in the UK Biobank","volume":"607","author":"B V Halldorsson","year":"2022","journal-title":"Nature"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41531-024-00752-9","article-title":"Loss-of-function variants in ITSN1 confer high risk of Parkinson's disease","volume":"10","author":"A T Skuladottir","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"issue":"02","key":"ref67","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajhg.2018.12.015","article-title":"Assessing the pathogenicity, penetrance, and expressivity of putative disease-causing variants in a population setting","volume":"104","author":"C F Wright","year":"2019","journal-title":"Am J Hum Genet"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"101035","DOI":"10.1016\/j.gimo.2024.101035","article-title":"P138: Evaluating the impact of gnomAD v4 on genetic prevalence estimates*","volume":"2","author":"S Baxter","year":"2024","journal-title":"Genet Med Open"},{"issue":"7726","key":"ref69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"C Bycroft","year":"2018","journal-title":"Nature"},{"issue":"6550","key":"ref70","doi-asserted-by":"crossref","first-page":"x","DOI":"10.1126\/science.abf8683","article-title":"Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity","volume":"373","author":"P Akbari","year":"2021","journal-title":"Science"},{"issue":"23","key":"ref71","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.2023023326","article-title":"Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank","volume":"143","author":"J Ryu","year":"2024","journal-title":"Blood"},{"issue":"7809","key":"ref72","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"K J Karczewski","year":"2020","journal-title":"Nature"},{"issue":"05","key":"ref73","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"P M Mannucci","year":"2004","journal-title":"Blood"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2017-04-780148","article-title":"Exploring the global landscape of genetic variation in coagulation factor XI deficiency","volume":"130","author":"R Asselta","year":"2017","journal-title":"Blood"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/ijms18122711","article-title":"Fibrinogen as a pleiotropic protein causing human diseases: the mutational burden of A\u03b1, B\u03b2, and \u03b3 chains","volume":"18","author":"E M Paraboschi","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41525-023-00375-8","article-title":"Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases","volume":"8","author":"O Seidizadeh","year":"2023","journal-title":"NPJ Genom Med"},{"issue":"16","key":"ref77","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/bloodadvances.2024013421","article-title":"Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis","volume":"8","author":"O Seidizadeh","year":"2024","journal-title":"Blood Adv"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant effect predictor","volume":"17","author":"W McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"K Jaganathan","year":"2019","journal-title":"Cell"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"P Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"M J Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"6664","key":"ref82","doi-asserted-by":"crossref","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"J Cheng","year":"2023","journal-title":"Science"},{"issue":"05","key":"ref83","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"P C Ng","year":"2001","journal-title":"Genome Res"},{"issue":"04","key":"ref84","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"I A Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"05","key":"ref85","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood.V95.5.1709.005k04_1709_1713","article-title":"Hypofibrinogenemia in an individual with 2 coding (\u03b382 A-->G and Bbeta235 P-->L) and 2 noncoding mutations","volume":"95","author":"S O Brennan","year":"2000","journal-title":"Blood"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MBC.0b013e328329f27a","article-title":"Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the \u03b3 Ala82Gly mutation","volume":"20","author":"J Zdziarska","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.thromres.2019.08.012","article-title":"Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations","volume":"182","author":"E Wypasek","year":"2019","journal-title":"Thromb Res"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/hmg\/ddv454","article-title":"A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration","volume":"25","author":"P S de Vries","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"11","key":"ref89","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1182\/blood-2015-02-624551","article-title":"Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF","volume":"126","author":"J E Huffman","year":"2015","journal-title":"Blood"},{"issue":"18","key":"ref90","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1093\/hmg\/ddac100","article-title":"Whole-exome sequencing of 14\u2009389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors","volume":"31","author":"N Pankratz","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"21","key":"ref91","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.2023022596","article-title":"Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles","volume":"144","author":"J E Huffman","year":"2024","journal-title":"Blood"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mbc.0000164430.98169.c6","article-title":"gammaAla82Gly represents a common fibrinogen \u03b3-chain variant in Caucasians","volume":"16","author":"V Ivaskevicius","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7616","key":"ref93","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"M Lek","year":"2016","journal-title":"Nature"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/s41467-021-23556-4","article-title":"Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes","volume":"12","author":"J K Goodrich","year":"2021","journal-title":"Nat Commun"},{"issue":"02","key":"ref95","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A \u03b1-chain amyloidosis","volume":"20","author":"J D Gillmore","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2511-3314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T23:34:31Z","timestamp":1755214471000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2511-3314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":94,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2025,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2511-3314","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}